Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Portfolio
Trending News
More News >
News
Enterprise Solutions
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Calculators
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
SYRE
Stock Latest News
The Fly
Leerink bullish on Spyre Therapeutics, initiates with an Outperform
2d ago
SYRE
Premium
The Fly
Spyre Therapeutics initiated with an Outperform at Leerink
2d ago
SYRE
Premium
Ratings
Promising Outlook for Spyre Therapeutics’ SPY003: Potential Game-Changer in IBD Treatment
13d ago
SYRE
Premium
The Fly
Spyre Therapeutics says first patient dosed in Phase 1 trial of SPY003
14d ago
SYRE
Premium
Ratings
Strategic Potential of Spyre Therapeutics in Combination Therapies for Inflammatory Diseases
24d ago
SYRE
Premium
The Fly
Spyre Therapeutics initiated with an Outperform at Wolfe Research
24d ago
SYRE
Premium
Company Announcements
Spyre Therapeutics Faces Compliance Hurdles After Transition from Smaller Reporting Company Status
1M ago
SYRE
Premium
Ratings
Buy Rating for Spyre Therapeutics: Promising Pipeline and Strategic Advancements Drive Growth Potential
1M ago
SYRE
Premium
Ratings
Buy Rating for Spyre Therapeutics Driven by Promising Drug Development and Strong Financial Position
1M ago
SYRE
Premium
Company Announcements
Spyre Therapeutics Reports Strong Progress and Financial Stability
1M ago
SYRE
Premium
The Fly
Spyre Therapeutics files $500M mixed securities shelf
1M ago
SYRE
Premium
The Fly
Spyre Therapeutics reports Q4 EPS (81c), consensus (94c)
1M ago
SYRE
Premium
Pre-Earnings
Spyre Therapeutics, Inc (SYRE) Q4 Earnings Cheat Sheet
1M ago
SYRE
Premium
The Fly
Spyre Therapeutics initiated with early-stage designation at Goldman Sachs
2M ago
SYRE
Premium
The Fly
Oruka Therapeutics initiated with an Outperform at Wolfe Research
2M ago
APGE
ORKA
Premium
The Fly
Spyre Therapeutics to be added to Nasdaq Biotechnology Index at open on 12/23
4M ago
SYRE
Premium
The Fly
TD says Spyre has ‘superior TL1A program’ after Teva data
4M ago
SNY
SYRE
Premium
The Fly
Spyre Therapeutics weakness after Teva data a buying opportunity, says BTIG
4M ago
SYRE
TEVA
Premium
The Fly
Spyre Therapeutics initiated with a Hold at JonesResearch
4M ago
SYRE
Premium
The Fly
Spyre Therapeutics announces first participants dosed in Phase 1 trial
4M ago
SYRE
Premium
The Fly
Spyre Therapeutics 7.275M share Spot Secondary priced at $27.50
5M ago
SYRE
Premium
Company Announcements
Spyre Therapeutics Faces Internal Control Challenges
5M ago
8K
SYRE
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
